These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 21985773

  • 1. Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literature.
    Ingegnoli F, Lubatti C, Ingegnoli A, Boracchi P, Zeni S, Meroni PL.
    Autoimmun Rev; 2012 Mar; 11(5):335-40. PubMed ID: 21985773
    [Abstract] [Full Text] [Related]

  • 2. The prognostic value of HRCT in myositis-associated interstitial lung disease.
    Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Aihara K, Ikezoe K, Watanabe K, Taguchi Y, Hatta K, Oga T, Chin K, Nagai S, Mimori T, Mishima M.
    Respir Med; 2013 May; 107(5):745-52. PubMed ID: 23485097
    [Abstract] [Full Text] [Related]

  • 3. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, Enomoto N, Inui N, Nakamura Y, Hosono Y, Imura Y, Mimori T, Suda T.
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.
    Cavagna L, Caporali R, Abdì-Alì L, Dore R, Meloni F, Montecucco C.
    J Rheumatol; 2013 Apr; 40(4):484-92. PubMed ID: 23418387
    [Abstract] [Full Text] [Related]

  • 5. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody.
    Kishaba T, McGill R, Nei Y, Ibuki S, Momose M, Nishiyama K, Nagano H, Yamashiro S.
    J Med Invest; 2018 Apr; 65(3.4):251-257. PubMed ID: 30282869
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis.
    Bonnefoy O, Ferretti G, Calaque O, Coulomb M, Begueret H, Beylot-Barry M, Laurent F.
    Eur J Radiol; 2004 Mar; 49(3):235-44. PubMed ID: 14962653
    [Abstract] [Full Text] [Related]

  • 9. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis.
    Yamasaki Y, Yamada H, Yamasaki M, Ohkubo M, Azuma K, Matsuoka S, Kurihara Y, Osada H, Satoh M, Ozaki S.
    Rheumatology (Oxford); 2007 Jan; 46(1):124-30. PubMed ID: 16754626
    [Abstract] [Full Text] [Related]

  • 10. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome.
    Zamora AC, Hoskote SS, Abascal-Bolado B, White D, Cox CW, Ryu JH, Moua T.
    Respir Med; 2016 Sep; 118():39-45. PubMed ID: 27578469
    [Abstract] [Full Text] [Related]

  • 11. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
    Yoshida N, Okamoto M, Kaieda S, Fujimoto K, Ebata T, Tajiri M, Nakamura M, Tominaga M, Wakasugi D, Kawayama T, Kuwana M, Mimori T, Ida H, Hoshino T.
    Respir Investig; 2017 Jan; 55(1):24-32. PubMed ID: 28012490
    [Abstract] [Full Text] [Related]

  • 12. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
    Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF.
    Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High-resolution computed tomography characterization of interstitial lung diseases in polymyositis/dermatomyositis.
    Hayashi S, Tanaka M, Kobayashi H, Nakazono T, Satoh T, Fukuno Y, Aragane N, Tada Y, Koarada S, Ohta A, Nagasawa K.
    J Rheumatol; 2008 Feb; 35(2):260-9. PubMed ID: 18085731
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.
    Sugiyama Y, Yoshimi R, Tamura M, Takeno M, Kunishita Y, Kishimoto D, Yoshioka Y, Kobayashi K, Takase-Minegishi K, Watanabe T, Hamada N, Nagai H, Tsuchida N, Soejima Y, Nakano H, Kamiyama R, Uehara T, Kirino Y, Sekiguchi A, Ihata A, Ohno S, Nagaoka S, Nakajima H.
    Arthritis Res Ther; 2018 Jan 11; 20(1):7. PubMed ID: 29325580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.